Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human Primates
暂无分享,去创建一个
Xiaona Jin | Fan Wang | Bing Jia | Jiyun Shi | Zhaohui Zhu | Huiyun Zhao | Fan Wang | Shuang Liu | Zhaofei Liu | Hui-yun Zhao | Jiyun Shi | Bing Jia | Fang Li | Xiaona Jin | Zhaohui Zhu | Shuang Liu | Zhaofei Liu | Fang Li
[1] Weibo Cai,et al. Imaging of integrins as biomarkers for tumor angiogenesis. , 2008, Current pharmaceutical design.
[2] Matthias Glaser,et al. Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients , 2008, Journal of Nuclear Medicine.
[3] M. Schwaiger,et al. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] Fan Wang,et al. Noninvasive imaging of tumor integrin expression using 18F-labeled RGD dimer peptide with PEG4 linkers , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[5] Fan Wang,et al. 68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Kowalsky Rj,et al. Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine, 2nd edition , 2006 .
[7] Horst Kessler,et al. Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD , 2005, PLoS medicine.
[8] Young-Seung Kim,et al. Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers. , 2009, Bioconjugate chemistry.
[9] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[10] Young-Seung Kim,et al. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. , 2009, Molecular pharmaceutics.
[11] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[12] Kara D. Weatherman,et al. Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine , 2011 .
[13] Horst Kessler,et al. Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man , 2006, Clinical Cancer Research.
[14] Weibo Cai,et al. Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.
[15] Shuang Liu. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. , 2009, Bioconjugate chemistry.